While QALY is a valuable tool, it has its limitations. One major criticism is that it may not fully capture the subjective experiences of cancer patients. Quality of life assessments can be highly personal and may not reflect the diverse experiences of individuals. Moreover, QALY does not account for the distribution of healthcare benefits among different populations, sometimes leading to ethical concerns. For instance, treatments with a high QALY for younger patients might not prioritize older patients, raising questions about equity.
